Cargando…
The Wnt pathway protein Dvl1 targets somatostatin receptor 2 for lysosome-dependent degradation
The Somatostatin receptor 2 (Sstr2) is a heterotrimeric G protein-coupled receptor that is highly expressed in neuroendocrine tumors and is a common pharmacological target for intervention. Unfortunately, not all neuroendocrine tumors express Sstr2, and Sstr2 expression can be downregulated with pro...
Autores principales: | Carr, Heather S., Zuo, Yan, Frost, Jeffrey A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164914/ https://www.ncbi.nlm.nih.gov/pubmed/36965619 http://dx.doi.org/10.1016/j.jbc.2023.104645 |
Ejemplares similares
-
SAT-313 Synaptojanin 2 Binding Protein Is Required for Efficient Somatostatin Receptor 2A Phosphorylation by G Protein Coupled Receptor Kinases and Signaling to the ERK/MAPK Pathway
por: Carr, Heather S, et al.
Publicado: (2020) -
Aberrant expression of SFRP1, SFRP3, DVL2 and DVL3 Wnt signaling pathway components in diffuse gastric carcinoma
por: Sremac, Maja, et al.
Publicado: (2021) -
USP9X Deubiquitylates DVL2 to Regulate WNT Pathway Specification
por: Nielsen, Casey P., et al.
Publicado: (2019) -
Wnt canonical pathway activates macropinocytosis and lysosomal degradation of extracellular proteins
por: Tejeda-Muñoz, Nydia, et al.
Publicado: (2019) -
ASPM promotes hepatocellular carcinoma progression by activating Wnt/β‐catenin signaling through antagonizing autophagy‐mediated Dvl2 degradation
por: Zhang, Haifeng, et al.
Publicado: (2021)